Product Development Policy | Research & Development | SENJU Pharmaceutica
ntribute to maintenance and improvement of “a joy to behold” or QOV (Quality of Vision) of patients worldwide. We launched senile cataract drugs in 1958, followed by a series of other products includi...
http://www.senju.co.jp/english/rd/policy/